Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Outcome Assessments in Encephalitis: A Systematic Review | Neurol Neuroimmunol Neuroinflamm | 2024 | 38086078 | PubTator, text mining | PubMed |
| Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome. | J Neurol | 2024 | 37999770 | PubTator, text mining | PubMed |
| Teratoma pathology and genomics in anti-NMDA receptor encephalitis. | Ann Clin Transl Neurol | 2024 | 37986706 | PubTator, text mining | PubMed |
| Role of FDG PET/CT in definitive and presumed autoimmune encephalitis. | Nucl Med Commun | 2024 | 37982572 | PubTator, text mining | PubMed |
| Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis. | Neurol Neuroimmunol Neuroinflamm | 2024 | 37949667 | PubTator, text mining | PubMed |
| Glial Fibrillary Acidic Protein Autoimmunity After Aseptic Meningitis: A Report of 2 Cases. | Neurol Neuroimmunol Neuroinflamm | 2024 | 37949666 | PubTator, text mining | PubMed |
| Neuropsychological Testing in Autoimmune Encephalitis: A Scoping Review. | Neurol Neuroimmunol Neuroinflamm | 2024 | 37949665 | PubTator, text mining | PubMed |
| Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis. | Neurol Sci | 2024 | 37940748 | PubTator, text mining | PubMed |
| Comprehensive exosomal microRNA profile and construction of competing endogenous RNA network in autism spectrum disorder: A pilot study. | Biomol Biomed | 2024 | 37865919 | PubTator, text mining | PubMed |
| Characterizing cognitive function in patients with autoimmune encephalitis: an Australian prospective study. | J Neurol | 2024 | 37709946 | PubTator, text mining | PubMed |
| Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study. | Neurol Sci | 2024 | 37580515 | PubTator, text mining | PubMed |
| Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases. | Med Clin (Barc) | 2024 | 37517931 | PubTator, text mining | PubMed |
| The three pillars in treating antibody-mediated encephalitis. | Wien Klin Wochenschr | 2024 | 37278857 | PubTator, text mining | PubMed |
| Anti-leucine-rich Glioma-inactivated 1 Protein-antibody Positive Encephalitis with Extensive Unilateral Cerebral Cortex and White Matter Lesions. | Intern Med | 2024 | 37225479 | PubTator, text mining | PubMed |
| Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis. | Eur Arch Psychiatry Clin Neurosci | 2024 | 37029805 | PubTator, text mining | PubMed |
| Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA). | Cerebellum | 2024 | 36991252 | PubTator, text mining | PubMed |
Heterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature. | Acta Epileptol | 2023 | 40217477 | PubTator, text mining | PubMed |
| A Prospective Observational Study of Autoimmune Encephalitis in Northwestern India. | J Assoc Physicians India | 2023 | 38700300 | PubTator, text mining | PubMed |
| Inpatient Burden of Neurological Disorders: A Route Map for Allocation of Resources and Postgraduate Training. | Cureus | 2023 | 38288171 | PubTator, text mining | PubMed |
| A Devastating Neurological Disorder: Anti-Dipeptidyl-Peptidase-Like Protein 6 (DPPX) Encephalitis Causing Rapidly Progressive Dementia. | Cureus | 2023 | 38274926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers?page=19